HopeStage
Back to all studies
CompletedNCT01944293

Ketamine Compared With Midazolam for Suicidal Thoughts in Bipolarity-Related Depression

About this title

Ketamine for Suicidality in Bipolar Depression

Read the official source — NCT01944293

Researchers compared ketamine and Midazolam to find out how the approaches affected suicidal thoughts in people with bipolarity during a depressive episode.

Medication studyAges 18–65United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared ketamine and Midazolam to find out how the approaches affected suicidal thoughts in people with bipolarity during a depressive episode.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2013
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01944293
Official title
Show the full official title

Ketamine vs. Midazolam in Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared ketamine and Midazolam to find out how the approaches affected suicidal thoughts in people with bipolarity during a depressive episode.

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including ketamine and Midazolam.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies